Register for this webinar to learn about screening for chronic kidney disease (CKD) in underserved populations. Gain access to the recording on demand through April 30, 2023.
DESCRIPTION
Chronic kidney disease is one of the top global health challenges. This challenge is compounded by the fact that many patients are unaware they have CKD. The first step in addressing this issue is to create awareness of CKD and the benefits of early screening. Prof. Nancy Brunzel led a discussion in 2021, hosted by AACC, addressing this challenge in light of the COVID-19 pandemic. Prof. Brunzel joins with Dr. Keiichi Sumida to discuss this global problem, particularly among underserved populations in both developed and developing countries. Dr. Sumida will share his research to raise awareness of the importance of chronic kidney disease screening, which can be performed by measuring urine albumin-to-creatinine ratio. Dr. Sumida will also discuss his research in determining urine albumin-to-creatinine ratio from urine protein results, which can be used in resource-limited communities.
TARGET AUDIENCE
This activity is designed for point of care coordinators, nurses (especially nephrology nurses and technicians), physicians (especially nephrologists, urologists, endocrinologists), clinicians, patients, providers, and researchers.
LEARNING OBJECTIVES
At the end of this activity, participants will be able to:
- Describe the importance of albumin-to-creatinine ratio in chronic kidney disease.
- Recognize the difference between urine dipstick protein and urine albumin-to-creatinine ratio.
- Explain how predicted ACR may be useful and informative.
FACULTY
Nancy Brunzel, MS, MLS(ASCP)CM
Assistant Professor (Retired)
University of Minnesota
Minneapolis, MN
Keiichi Sumida, MD, MPH, PhD
Associate Professor
Division of Nephrology, Department of Medicine
University of Tennessee Health Science Center
Memphis, TN
DISCLOSURES AND STATEMENT OF INDEPENDENCE
AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported the following relevant financial relationship:
- Keiichi Sumida, MD, MPH, PhD
Consultant Fees: Siemens Healthcare Diagnostics
The following faculty reported no relevant financial relationship:
- Nancy Brunzel, MS, MLS(ASCP)CM
CONTENT VALIDITY
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
ACCREDITATION STATEMENT
This activity is approved for 1.0 ACCENT credit(s) by AACC. Activity ID# 4047. This activity was planned in accordance with ACCENT Standards and Policies.
SUCCESSFUL COMPLETION STATEMENT
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].